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A B S T R A C T
Background: Despite high projected burden, hypertension incidence data are lacking in South Asian
population.Wemeasured hypertension prevalence and incidence in the Center for cArdio-metabolic Risk
Reduction in South Asia (CARRS) adult cohort.
Methods: The CARRS Study recruited representative samples of Chennai, Delhi, and Karachi in 2010/11,
and socio-demographic and risk factor data were obtained using a standard common protocol. Blood
pressure (BP) was measured in the sitting position using electronic sphygmomanometer both at baseline
and two year follow-up. Hypertension and control were deﬁned by JNC 7 criteria.
Results: In total, 16,287 participants were recruited (response rate = 94.3%) and two year follow-up was
completed in 12,504 (follow-up rate = 79.2%). Hypertensionwas present in 30.1%men (95% CI: 28.7–31.5)
and 26.8% women (25.7–27.9) at baseline. BP was controlled in 1 in 7 subjects with hypertension. At two
years, among non-hypertensive adults, average systolic BP increased 2.6mm Hg (95% CI: 2.1–3.1),
diastolic BP 0.7mmHg (95% CI: 0.4–1.0), and 1 in 6 developed hypertension (82.6 per 1000 person years,
95% CI: 80.8–84.4). Risk for developing hypertensionwas associatedwith age, low socio-economic status,
current alcohol use, overweight, pre-hypertension, and dysglycemia. Risk of incident hypertension was
highest (RR= 2.95, 95% CI: 2.53–3.45) in individuals with pre-hypertension compared to normal BP.
Collectively, 4 modiﬁable risk factors (pre-hypertension, overweight, dysglycemia, and alcohol use)
accounted for 78% of the population attributable risk of incident hypertension.
Conclusion: High prevalence and poor control of hypertension, along with high incidence, in South Asian
adult population call for urgent preventive measures.
© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Hypertension is a common risk factor for cardiovascular disease
(CVD) and a major global public health problem [1]. Globally,
hypertension affects approximately one in four adults [2] and
results in over ten million deaths annually [3]. Furthermore, low-
and middle-income countries (LMIC) contribute to nearly two-
thirds of the mortality attributable to hypertension [4]. Although
the average systolic blood pressure (SBP) is decreasing worldwide
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since 19800s at the rate of 1mmHg SBP per decade, it is increasing
in LMICs, especially in the South Asian population [5]. There are
several studies that document the prevalence of hypertension in
South Asian countries [6–8], and numerous meta-analyses have
unequivocally demonstrated that treating and effectively lowering
blood pressure (BP) is associated with reductions in cardiovascular
events and mortality [9,10]. However, the treatment and control
among prevalent hypertension cases are relatively poor in resource
poor settings, though data are quite limited and little is known
about hypertension management in South Asia [6].
Studies conducted in the Indian sub-continent suggest that
hypertension onset occurs relatively early in life [11] and is often
associated with clustering of multiple cardiovascular diseases risk
factors [12]. However, there is paucity of data on the incidence and
factors associated with progression to hypertension in this
population. Reliable data on hypertension incidence is important
to estimate the future burden of hypertension and to identify
potential risk factors and subpopulations to target with preventive
interventions.
In this report, we used data from a large, urban population
cohort representative of three large cities in South Asia with the
objective to examine prevalence, treatment and control, two year
incidence, and factors associated with incident hypertension.
2. Methods
2.1. Population
The CARRS Study [13] recruited representative population
cohorts of threemetropolitan urban cities in south Asia with large,
growing, and heterogeneous populations, namely Chennai, Delhi
and Karachi. The cities were [3_TD$DIFF]chosen based on convenience. The
detailed methods including sample selection and measurements
have been published elsewhere [13]. Brieﬂy, households were
selected in each of the three cities using a multi-stage cluster
random sampling technique (selection of districts followed by
random selection of municipal wards or census enumeration
blocks and ﬁnally the selection of households within these
sampling units) to ensure representativeness of the population.
Two participants, oneman and onewoman, aged 20 years or older,
were selected from each household based on “Kish method” as
used in the WHO’s STEPS surveys [14].
2.2. Measurements
Trained ﬁeld workers collected socio-demographic and risk
factor data from all eligible participants using a structured
questionnaire. Baseline assessment was done in year 2010–11.
They also measured height, weight, waist circumference, systolic
and diastolic BP from all participants using standardized equip-
ment and measurement techniques. Blood pressure was recorded
in the sitting position using electronic sphygmomanometer;
Omron HEM-7080 and HEM-7080IT-E; Omron Corporation, Tokyo,
Japan (certiﬁed by the British Hypertensive Society and the
American association for Advancement of Medical Instrumenta-
tion [AAMI] protocols). A minimum of 2 measurements were
taken, and 5min apart. A third reading was also taken if the
difference between ﬁrst and second readings were10 or5mm
Hg for systolic and diastolic BP, respectively. The mean of the last
two was used for analyses. Additionally, fasting blood samples
were also collected for biochemistry analyses. Standard assay
methods for assessment of diabetes (plasma glucose, haemoglobin
A1c) and dyslipidemia (total cholesterol, VLDL-cholesterol, LDL-
cholesterol, HDL-cholesterol and triglycerides) were used across
the three sites. All laboratories participated in an external quality
assurance program (RIQAS) from RANDOX for clinical chemistry,
lipids andHbA1c. Performance of all participating labswerewithin
the acceptable levels of<2 in the Cycle Average StandardDeviation
Index (score close to zero indicates optimal performance) for all
the parameters in the RIQAS. A summary of all surveillance
indicators, measures, methods and instruments used in the study
has been published in detail [13].
2.3. Annual follow-up
Trained ﬁeld workers contacted all the study participants in the
baseline survey annually and collected information on risk factors
using a structured questionnaire. Additionally, anthropometry
measurements and blood pressure readings were taken from all
eligible participants during the second year follow-up.We used the
same make of equipment for BP and anthropometric measure-
ments, and standardization procedures for all study related
measurements in the annual surveys as in the baseline survey.
Year-2 follow-up was conducted in 2013-14.
2.4. Deﬁnitions
2.4.1. Hypertension prevalence, awareness, and treatment
Hypertension was deﬁned as SBP of 140mmHg and/or a
diastolic blood pressure (DBP) of 90mmHg and/or self-reported
treatment for hypertension. Similarly, incident hypertension was
deﬁned as follow-up SBP of140mmHg and/or DBP of90mmHg
and/or self-reported diagnosis of hypertension by a qualiﬁed
physician among thosewhowere not hypertensive at baseline [15].
Pre-hypertension was deﬁned as SBP of 120 and/or DBP of 80
among individuals without hypertension. Incidencewas estimated
in individuals without hypertension at baseline.
To estimate awareness, treatment, and control of hypertension,
we used the common denominator of total number of individuals
with hypertension. Participants who had been told that they had
hypertension by a healthcare professional and self-reported their
status were categorised as ‘aware’, and thosewho reported current
use of prescribed anti-hypertensivemedication/s were categorised
as ‘treated’. ‘Control of hypertension’ was deﬁned as having an
average of <140 and <90mmHg for SBP and DBP, respectively, in
hypertensive subjects at baseline. Parental history of hypertension
was deﬁned as self-reported status of treatment of hypertension in
parents when they were <60years old.
2.4.2. Socioeconomic Status (SES)
Household asset index and educationwere used to describe the
SES of each participant. Principal components analysis was used to
estimate cumulative household assets based on weighted scores
for ownership of different household assets. Asset scoreswere then
divided into tertiles of SES [16]. Education categories included in
the analyses were ES1; “graduation & above”, ES2; “up to
secondary”, ES3; “up to primary”, and ES4; “illiterates or
individuals with no formal education”.
2.4.3. Others covariates
Physical activity was assessed using International Physical
Activity Questionnaire (IPAQ). Waist circumference was used to
deﬁne central obesity (men:90 cm andwomen:80 cm). A body
mass index (BMI) of 25kg/m2 was deﬁned as overweight.
Diabetes was deﬁned as having either HbA1c value more than
equal to 6.5% or fasting blood glucose more than equal to 126mg/
dL or self-reported glycemia-lowering medications. Prediabetes
was deﬁned as having HbA1c value between 5.7 to 6.5% and/or
fasting glucose between 100 and 125mg/dL. Dysglycemia was
deﬁned as either pre-diabetes or diabetes. Chronic kidney disease
(CKD) status was derived from serum creatinine based estimated
glomerular ﬁltration rate (eGFR) measurements using the Chronic
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Kidney Disease Epidemiology Collaboration (CKD-EPI) [17] study
equation. An eGFR of less than 60ml/min/1.73m2 was deﬁned as
CKD. We did not have data from Karachi on serum creatinine.
2.4.4. Research ethics oversight
The Institutional Review Boards (IRBs) of the Public Health
Foundation of India, New Delhi, All India Institute of Medical
Sciences, New Delhi, Madras Diabetes Research Foundation,
Chennai, India, Aga Khan University, Karachi, Pakistan, and Emory
University, Atlanta, USA approved the CARRS study. All respond-
ents gave written informed consent, themselves or through a next
of kin/family member in the case of illiterate respondents, prior to
enrolment and participation in the study.
2.4.5. Statistical analyses
The characteristics of the study population were summarized
separately for men and women. The data were presented as mean
with their standard deviation (SD) for continuous variables or as
percentages for categorical variables. All estimates of mean BP,
prevalence and incidence of hypertension were age-standardized
to the 2010 World Bank regional population. Estimates were also
adjusted based on survey weights to account for population
representation due to sampling at different levels in each cluster.
Prevalence estimates were calculated after accounting for the
complex multi-stage survey design, stratiﬁcation, and sampling
weights.
Incidence of hypertension was estimated using follow-up data
collected up to the second year among non-hypertensive
individuals at baseline. Uneven response rate in the follow-up
surveys in different risk groups was adjusted by inclusion of
weights generated for non-response. Initially, logistic regression
model coefﬁcients were generated to estimate the probability of
non-response after adjusting for baseline variables such as location
(city), age, sex, education, tobacco use, BMI, pre-hypertension and
diabetes. Further, we used an inverse propensity score as a weight
in estimating the incidence of hypertension. Incidence rates were
calculated per 1000 person years of follow-up and also as
cumulative percentages over two year follow-up period with their
95% conﬁdence intervals. Generalised linear model with Poisson
family was employed to calculate the incidence relative risk ratio
(RR) of potential risk factors of hypertension. Multivariable models
included all baseline variables that were associated with incident
hypertension in the bivariate models at 2nd year follow-up
(p<0.05). Parental history of blood pressure before age 60was also
included in the multivariable model. Analyses were repeated after
imputing missing co-variates at baseline by using multiple
imputation involving chained equations. The methods of multiple
imputation have been explained elsewhere [18]. Proportion of data
missing ranged from 1% for socio-demographic data to 23% for
body weight. Multiple imputation was done using multiple
imputation chained equations (MICE) approach for all missing
observations in the exposure variables of interest at baseline. Ten
imputed datasets were generated. Imputed values of missing
continuous variables were modelled using linear regression and
predictive meanmatching, and imputed values of ordinal variables
were modelled using ordinal logistic regression. Model conver-
gence was checked, and diagnostics were performed on the
imputed dataset. Population attributable fraction (PAF) of major
modiﬁable risk factors were also estimated directly from the RR
coefﬁcients (Box 1, online supplement).
3. Results
3.1. Enrolment and response rate
We approached a total of 17,274 individuals in 10,002 house-
holds in the three study sites and 16,287 participants were
recruited (the overall response rate was 94.3% at the participant
level; 6906 Chennai [90.9%], 5364 Delhi [98.9%], and 4017 Karachi
[94.3%]). There were 2393 households with single subjects (827
males and 1566 females). Fasting blood samples were collected at
baseline from 13,720 of the participants (response rate = 84.2%).
The response rate in the ﬁrst, second and either of the initial two
annual follow-up surveys were 78.6%, 79.2% and 93.2%, respec-
tively. Individuals with elevated levels of CVD risk factors (for
example; elevated BP in the prehypertension range) responded
more than individuals with all optimal level risk factors. In the
second annual follow-up survey the odds of participation among
tobacco users [OR: 1.19; 1.04–1.36], and individuals with pre-
hypertension [OR: 1.18; 1.02–1.36] were high as compared to non-
users and normotensives, respectively.
3.2. General characteristics of the study population
The mean age (SD) of the populationwas 42 years (13.3) and 40
years (12.9) in men and women, respectively. Womenwere 52% of
the study population. Nearly 55% of men and 41% women reported
more than secondary education, and one of ﬁve individuals was
either illiterate or had no formal education (Table 1). Men were
relatively older in Karachi (mean age 43.2, SD=16.2 years) as
Table 1
General characteristics of the study population.
Variables Chennai Delhi Karachi Total
Men
(N=3188)
Women
(N=3718)
Men
(N=2680)
Women
(N=2684)
Men
(N=1892)
Women
(N=2125)
Men
(N=7760)
Women (N=8527)
Mean age (SD) 41.04 (13.1) 39.25 (11.9) 42.20 (11.8) 41.23 (11.1) 43.16 (16.2) 40.01 (12.9) 41.96 (13.3) 40.12 (12.9)
Education, %
ES1 16.2 9.3 29.3 24.4 18.4 9.8 21.7 14.8
ES2 35.7 27.3 31.8 24.4 33.0 26.2 33.6 26
ES3 36.4 44.1 26.9 24 28.0 21.6 30.9 31.9
ES4 11.8 19.2 12.0 27.2 20.7 42.5 13.8 27.3
Socio economic status,
%
High 18.4 18.8 44.7 45.3 37.1 32.9 32.7 31.3
Medium 37.6 35.2 24.9 23.5 47.1 48.1 34.8 34.0
Low 44.0 46.1 30.4 31.2 15.8 19.1 32.5 34.7
ES1 = educational status (above graduates), ES2= secondary school education, ES3=primary school and above, ES4 = lower than primary or no formal education or illiterates.
High is third tertile, medium is second tertile, low is ﬁrst tertile in the principal component analysis score.
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compared to Chennai (41.0, 13.1) and Delhi (42.2, 11.8). Less than
primary school education among participants was more frequent
in Karachi than Chennai or Delhi (Table 1).
3.3. Mean blood pressure levels
Themean SBPwas highest in Delhi (men; 12917 [14_TD$DIFF] andwomen;
12118mmHg) and lowest in Karachi (men; 12320 and women
11723mmHg). In older age groups, mean SBP was higher in both
men (mean SBP in < =24 and > =65 years age group: 117.4 and
140.1mmHg) and women (105.1 and 139.3mmHg) (Table S1). DBP
was also elevated in higher age groups until the age of 64 years and
then started showing a decline especially in Delhi.
3.4. Prevalence, awareness, treatment and control of hypertension
Consistent with the mean blood pressure levels, the age
adjusted prevalence of hypertension in men was highest in Delhi
(37%) and lowest in Karachi (24%). Twenty eight percent of women
in Delhi and Karachi were hypertensive, and in Chennai, 29% men
and 25% womenwere so (Fig. S1). The prevalence was higher with
age in both men and women (Table S2). Hypertension prevalence
was particularly high in men 24 years in Delhi in comparison to
adults of same age category in other cities (Table S2). Prehyper-
tension was prevalent in nearly one third (30.3%) of the study
population (men: 36%, and women: 25.2%) and the overall
prevalence was highest in Delhi (33.3%) and lowest in Karachi
(26.5%) (Fig. S1).
Among those with hypertension at baseline, awareness levels
were highest in Karachi (men; 27% andwomen; 57%). Theywere 24
and 38% respectively, in Chennai and 22 and 36% respectively, in
Delhi. Overall, treatment and control levels of hypertension,
respectively, were very low in Delhi (men; 18 and 7%, women; 33
and 16%) and Chennai (men; 22 and 10%, women; 37 and 20%).
More than half of women (55%) in Karachi were treated for
hypertension, while BP control status was observed in 27% (Fig. 1
and Table S3).
Although hypertension control rates were higher in individuals
with established disease conditions such as diabetes (22.9%),
chronic kidney disease (22.4%), heart disease (38.2%), and stroke
(32.2%), they were still far less than optimal level (Table S4). Based
on self-reported data at the time of the survey, more than two third
(68.3%) of individuals with known hypertensionwere taking drugs
regularly.
Hypertension awareness, treatment, and control showed a
positive linear relationship with educational status (the rates were
lowest in illiterate or participants with no formal education and
highest in participants with more than graduate level education)
only in men (Fig. S2). However, hypertension prevalence was not
associated with educational status.
3.5. Incidence of hypertension
The mean SBP and DBP each increased in bothmen and women
without hypertension at baseline during the two year follow-up
period (Fig. S3). The highest secular increase in SBP was in women
in the older age groups ( > 55years) (Table S5). On average SBP
increased by 2.6mm Hg (95% CI: 2.1–3.1) and DBP by 0.7mm Hg
(95% CI: 0.4–1.0) over a mean follow up of 2 years. One of six
participants without hypertension (16.2%) at baseline developed
hypertension during the 2 year follow-up period. The overall age
and non-response rate adjusted incidence rate was 82.6 per 1000
person-years (95% CI: 80.8–84.4), whereas the incidence rate
adjusted only for non-response rate was 74.6 per 1000 person-
years (95% CI: 70.5–79.1) (Table S6 and Table 2). Age adjusted
incidence was highest in Delhi (94, 72 and 69 per 1000 person
years of follow-up in Delhi, Chennai and Karachi, respectively).
Nearly 9 of 10 incident cases (87.9%) were detected at the time of
second year survey. Overall, there were no differences in the
incidence of hypertension in men and women (Fig. 2). The
incidence of hypertension, however, was lower in women than in
men in the younger age group (<55years), but was higher in
women than men in the older age group (55 years). Incidence of
hypertensionwas more than two times higher in participants with
pre-hypertension in all age groups at baseline than those with
normal blood pressure (Fig. S4).
3.6. Predictors of incident hypertension
Hypertension incidence was similar in men and women
(adjusted RR=1.08, 95% CI: 0.92–1.26) in the multi-variable
regression model. Hypertension incidence rate was positively
and linearly associated with age, and inversely and linearly
associated with educational status (Table 2). Overweight (BMI
25.0 kg/m2) was associated with 28% higher incidence of
hypertension than those with BMI 18–23kg/m2 (RR=1.28; 95%
CI: 1.04-1.59). Current alcohol use was associated with a 34%
higher risk of hypertension relative to non-drinkers (RR=1.34, 95%
CI: 1.10–1.62). Presence of dysglycemia at baseline was associated
[(Fig._1)TD$FIG]
Fig.1. Prevalence, awareness, treatment and control of hypertension in adults over 20-years of age in three South Asian cities. The denominator for awareness, treatment and
control are all individuals with hypertension at baseline.
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Table 2
Incidence [2_TD$DIFF]and risk factors for hypertension.
Variables N Un-adjusted incidence
rate per 1000 p-y (95% CI)
Adjusted incidence rate
per 1000 p-y (95% CI)
Q
Unadjusted RR,
CI
Adjusted RR,CI
(n = 6250)
Adjusted RR,CI
(without Karachi)L=
(n =4680)
Adjusted RR, CI
(Missing co-variates
imputed at baseline)
Overall 8146 80.5 [76.3,85.0] 74.6[70.5,79.1]
City
Chennai 3528 76.0[69.6,83.1] 71.5[65.4,78.2] 1 1 1 1
Delhi 2408 95.7[87.6,104.6] 93.6[85.8,102.2] 1.54z [9_TD$DIFF] 1.36,1.74] 1.27**
[1.09,1.47]
1.21*[1.04,1.41] 1.28***[1.12,1.47]
Karachi 2210 70.4[63.3,78.3] 69.0[62.0,76.9] 1.16* [1.01,1.33] 1.20 [1.00,1.44] NA 1.23* [1.05, 1.45]
Age groups, years
20–24 718 28.6[21.1,38.7] 26.8[19.2,38.6] 1 1 1 1
25–34 2346 50.1[44.1,56.9] 45.1[39.3,52.0] 1.63**[1.12,2.36] 1.38 [0.89,2.13] 1.33 [0.76,2.35] 1.37 [0.94, 2.00]
35–44 2588 74.8[67.7,82.6] 65.2[58.6,72.8] 2.38z[1.66,3.41] 1.62*
[1.05,2.48]
1.65 [0.95,2.88] 1.64** [1.13, 2.37]
45–54 1530 113.9[102.5,126.5] 110.1[98.9,122.8] 3.99z[10_TD$DIFF] 2.78,5.71] 2.35z
[1.52,3.63]
2.32z [1.33,4.06] 2.42z [1.66,3.52]
55–64 670 160.9[140.8,183.8] 162.1 [143.2,184.3] 5.97z [11_TD$DIFF] 4.15,8.61] 3.44z
[2.21,5.35]
3.45z [1.95,6.09] 3.46z [2.36,5.07]
6565 294 147.2[119.5,181.5] 152.9[125.9,187.7] 5.71z [12_TD$DIFF] 3.84,8.48] 3.15z
[1.96,5.06]
3.38z [1.86,6.16] 3.08z [2.04,4.65]
Sex
Female 4627 70.9[65.7,76.5] 65.4[60.3,71.1] 1 1 1 1
Male 3519 93.1[86.3,100.5] 92.3[85.3,99.9] 1.43z [9_TD$DIFF] 1.28,1.60] 1.08 [0.92,1.26] 1.17 [0.98,1.40] 1.05 [0.92, 1.21]
Education
ES1 1385 75.7[66.3,86.5] 67.0[58.3,77.3] 1 1 1 1
ES2 2442 77.8[70.4,86.0] 71.6[64.5,79.8] 1.02 [0.85,1.22] 1.15 [0.95,1.39] 1.15 [0.93,1.44] 1.13 [0.95, 1.34]
ES3 2672 80.8[73.4,88.8] 75.1[68.0,83.2] 1.04[0.87,1.24] 1.19 [0.98,1.45] 1.23 [0.99,1.54] 1.14 [0.95, 1.36]
ES4 1647 88.3[78.8,99.0] 85.8[76.3,97.0] 1.24*[1.03,1.49] 1.29*
[1.05,1.60]
1.25*[0.97,1.61] 1.23* [1.02, 1.49]
BMI, kg/m2
<18.00 454 40.5[29.5,55.7] 34.0[24.3,49.0] 0.65*[0.45,0.94] 0.73
[0.50,1.07]
0.82[0.53,1.25] 0.82 [0.60, 1.12]
18.0022.99 2010 59.1[52.1,67.1] 54.3[47.6,62.2] 1 1 1 1
23.0024.99 1031 79.7[68.3,93.0] 72.5[62.1,85.2] 1.31**[1.07,1.61] 1.14 [0.92,1.42] 1.05 [0.82,1.34] 1.10 [0.91, 1.34]
25.00 3272 98.6[91.2,106.6] 87.7[81.1,95.0] 1.57z[9_TD$DIFF] 1.34,1.83] 1.28*
[1.04,1.59]
1.18 [0.91,1.52] 1.25* [1.03, 1.52]
Waist
circumference,
cm
Non obese 3917 60.0[54.8,65.7] 55.2[50.1,61.1] 1 1 1 1
Obese 4229 99.4[92.9,106.3] 89.5[83.4,96.1] 1.63z [9_TD$DIFF] 1.44,1.84] 1.04 [0.86,1.26] 1.05 [0.84,1.32] 1.06 [0.90, 1.27]
Tobacco use
Never users 6326 75.8[71.2,80.8] 70.4[65.8,75.3] 1 1 1 1
Ever users 1820 96.6[87.1,107.1] 96.5[86.9,107.5] 1.41z[9_TD$DIFF] 1.24,1.59] 1.08 [0.92,1.27] 1.04 [0.86,1.26] 1.09 [0.95, 1.26]
Current alcohol use
No 7231 75.8[71.4,80.4] 70.8[66.5,75.5] 1 1 1 1
Yes 915 119.3[104.3,136.4] 113.2[98.8,130.3] 1.55z [9_TD$DIFF] 1.33,1.80] 1.34**
[1.10,1.62]
1.25**[1.02,1.54] 1.37z[9_TD$DIFF] [1.15,1.63]
Physical Activity
Low 811 92.9[79.6,108.5] 85.0[72.8,100.0] 1 1 1 1
Medium 2181 84.7[76.7,93.6] 77.6[69.8,86.5] 0.88[0.73,1.07] 0.94 [0.76,1.16] 1.01 [0.77,1.33] 0.96 [0.80, 1.15]
High 5154 76.5[71.3,82.1] 72.3[67.1,78.0] 0.76**[0.63,0.90] 1.03 [0.85,1.26] 1.00 [0.77,1.30] 1.03 [0.86, 1.23]
Glycemic status
Normal 2892 123.9[111.0,138.4] 49.7[44.3,55.8] 1 1 1 1
Diabetes 1282 83.5[76.4,91.1] 119.2[106.9,133.2] 2.39z[9_TD$DIFF] 2.04,2.80] 1.27*[1.05,1.53] 1.32* [1.06,1.64] 1.22* [1.03, 1.44]
Pre-diabetes 2977 54.4[48.7,60.8 77.3[70.7,84.8] 1.56z [9_TD$DIFF] 1.34,1.80] 1.12 [0.96,1.32] 1.14 [0.94,1.39] 1.09 [0.95, 1.26]
Parental history of
hypertension
No 6896 82.1[77.5,87.0] 74.9[70.4,79.8] 1 1 1 1
Yes 1250 71.9[62.2,83.2] 73.2[62.9,85.6] 0.97 [0.83,1.15] 1.11 [0.93,1.32] 1.20 [0.99,1.47] 1.10 [0.93, 1.29]
eGFR, ml/min/
1.73m2
> =60 7137 77.8[73.3,82.5] 73.3[69.0,78.0] 1 NA 1 NA
<60 121 142.4[103.2,196.5] 128.7[95.5,177.4] 1.94z [9_TD$DIFF] 1.42,2.66] 1.10 [0.69,1.74]
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with higher incidence of hypertension (RR for diabetes =1.27, 95%
CI: 1.05–1.53 and RR for pre-diabetes = 1.12; 95% CI: 0.96–1.32) in
comparison to participants with normal glycemic levels. Incident
hypertensionwas three times higher (RR=2.95, 95% CI: 2.53–3.45)
in individuals with pre-hypertension at baseline in comparison to
individuals with normal BP. Regression results were comparable in
the complete case analyses and in the analyses with imputed
missing covariates at baseline (Table 2). Collectively, 4 modiﬁable
risk factors (pre-hypertension, overweight, dysglycemia, and
alcohol use) accounted for 78% [6_TD$DIFF]of the population attributable risk
of incident hypertension (Table S7).
4. Discussion
Based on population-based data from adults over 20 years of
age from three large cities in South Asia, we estimated that on an
average, one of three men and one of four women have
hypertension. Hypertension awareness, treatment, and control
are alarmingly low. Among non-hypertensive subjects, one of six
adults developed hypertension over a two year period, probably
the highest incidence reported in the world. Propensity to develop
hypertension was higher among older, low socio-economic status
participants, current alcohol users, and individuals characterized
as overweight, pre-hypertensive and dysglycemic. The rate of
progression from pre-hypertension to hypertension is three times
higher than that of individuals with normal BP.
Our study ﬁndings on prevalence, awareness, and treatment of
hypertension are consistent with previously reported data from
the Indian sub-continent [6,19,20]. The incidence of hypertension
among one of six adults over a two year period is a great cause of
concern. It was signiﬁcantly higher than the incidence data
reported from developed countries [21,22]. In absolute terms, this
translates tomore than doubling of the prevalence of hypertension
(assuming that the same rate continues for a decade) in a span of
ten years with a corresponding 243% and 271% increase among
men and women, respectively. Our ﬁndings imply that the
previous estimates by Kearney and colleagues on the prevalence
of hypertension by 2025 (25% increase) is probably an under-
estimate [2]. The anticipated increase in hypertension prevalence,
in concurrence with a projected increase in prevalence of diabetes
in this population [23], will lead to dramatic rises in the incidence
of cardiovascular diseases.
Table 2 (Continued)
Variables N Un-adjusted incidence
rate per 1000 p-y (95% CI)
Adjusted incidence rate
per 1000 p-y (95% CI)
Q
Unadjusted RR,
CI
Adjusted RR,CI
(n =6250)
Adjusted RR,CI
(without Karachi)L=
(n = 4680)
Adjusted RR, CI
(Missing co-variates
imputed at baseline)
Baseline blood
pressure levels,
mmHg
Normal BP 4420 38.0[34.1,42.3] 35.7[31.8,40.3] 1 1 1 1
Pre-hypertension 3726 131.1[123.1,139.6] 129.4 [121.5,137.9] 3.62z [9_TD$DIFF] [3.17,4.14] 2.95z
[2.53,3.45]
3.3z[2.74,4.04] 2.90z[9_TD$DIFF] [2.52,3.34]
Years of follow-up 1.22**[1.08, 1.38] 1.23** [1.06,
1.41]
1.22* [1.04, 1.41] 1.18* [1.04, 1.35]
*p<0.05, **P<0.01, [13_TD$DIFF]zp<0.001, RR=relative risk ratio.
Q
Adjusted for uneven response rate in different risk groups, L=model includes serum creatinine based eGFR measurements from Delhi and Chennai (data are not available in
Karachi). p-y =person years, ci = conﬁdence interval, eGFR= estimated glomerular ﬁltration rate, BMI = body mass index, ES1 = educational status (above graduates),
ES2 = secondary school education, ES3 =primary school and above, ES4= lower than primary or no formal education or illiterates.
[(Fig._2)TD$FIG]
Fig. 2. Incidence of hypertension stratiﬁed by age groups in men and women. Incidence rate is given per 1000 person years of follow-up.
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We report that the risk for progression to hypertension in this
population is associated with several socio-demographic (age, and
educational status) and biological factors (overweight, blood
pressure levels, and dysglycemia). Unlike the previous studies
where they had used prevalent hypertension [24,25], the outcome
variable in our analyses was incident hypertension, conﬁrming
temporality of association. Some ﬁndings of public health
signiﬁcance are that the incidence of hypertension in individuals
with pre-hypertension is more than three times than in those with
normal BP, and furthermore, it is considerably higher in older age
groups. Even at younger age groups, hypertension incidence risk is
signiﬁcantly higher in individuals with pre-hypertension than in
those with normal BP. Risk stratiﬁcation and targeted preventive
strategies among non-hypertensive persons who are at greatest
risk for progression to hypertension may help prevent the rapid
rise in prevalence of hypertension.
Although the overall incidence of hypertension was similar in
men and women, the pattern was distinctly different in older and
younger age groups. The advantagewomen had in the younger age
group is completely offset by higher incidence of hypertension in
the older age group in comparison to men. This may be due to
changes in the level of endogenous sex hormones in the post-
menopausal age group as they are associated with greater
longitudinal rise in BP [26]. The predilection of hypertension
was 28% higher in participants above the BMI of 25 kg/m2, in
comparison to individuals with BMI of 18–22.99 kg/m2, after
adjustment of the effect of waist circumference and other potential
confounding variables. However, it was similar in individuals with
BMI of 23–24.99 kg/m2 and in individuals with BMI of 18–22.99 kg/
m2. This implies that the overweight cut-off of BMI >23 kg/m2 as
suggested by some of the authors [27] are probably not relevant for
hypertension risk stratiﬁcation in South Asian settings.
The susceptibility to develop hypertension is higher in lower
educated groups. These ﬁndings afﬁrm our previous observations
[28,29] and is in contrast to the opinion expressed by a selected
group of authors that non-communicable diseases and their risk
factors are not a problem in poor communities [30]. The social
gradient in hypertension has profound implications for the
countries and the health care system in south Asia. As described
in our study, a large majority of the incident hypertension remain
undiagnosed in the absence of regular surveillance. They are more
likely to result in complications of hypertension. Even if they are
identiﬁed earlier, the probability of receiving treatment will be
relatively low especially among individuals in the low socio-
economic strata. Further it is well-established that majority of
patients with hypertension will require [7_TD$DIFF]two or more drugs to
achieve BP control [31]. In this context, the high incidence rate of
hypertension will also have huge ﬁnancial implications for drug
requirements. With families and individuals spending a signiﬁcant
proportion of their income for health care in South Asian countries
especially in the lower socio-economic strata, the impact of the
rising prevalence of hypertension on household economy is
substantial.
4.1. Strengths and limitations
Prevalence and incidence estimates based on representative
population-based sample from three large cities in South Asia,
standardized measurement techniques, uniform study protocol
and estimates after accounting for the complex study design are
the major strengths of the study. The response rate in the baseline
and follow-up surveys are very high. The incidence estimates are
also adjusted for relatively lower non-response rate in the follow-
up surveys. Finally, generalizability of our ﬁndings is limited to
adult men and women living in metropolitan cities in the Indian
sub-continent.
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